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Abstract Ethylene oxide and propylene oxide block copolymers
(pluronics) are widely known as agents that promote drug
penetration across biological barriers. We have studied the
interaction of normal and malignant blood cells with pluronics
L61 and P85 that have different hydrophobicity. SP2/0 myeloma
cells accumulated pluronics while normal cells adsorb most of the
polymer on the surface. Interaction of pluronics with cells
resulted in drastic changes of membrane microviscosity. Tumor
cell membrane microviscosity decreased after pluronics adsorp-
tion, in contrast to normal cells, whose membrane microviscosity
was enhanced. We suppose that sensitivity of tumor cell
membrane microviscosity to the pluronics action correlates with
its permeability for molecular substances.
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1. Introduction
Ethylene oxide and propylene oxide block copolymers are
widely used in pharmacology as components of arti¢cial
blood [1^3], vaccines [4], agents for drug solubilization [5,6]
and thermotropic gels for drug delivery [7,8]. In a number of
papers, pluronics were reported as promoting drug penetra-
tion across di¡erent biological membranes (e.g. cell membrane
[9,10], the blood-brain barrier [11], and skin [12,13]). Recently
it has been shown that pluronics L61 and P85 dramatically
enhance the sensitivity of gP-170 containing multi-drug resist-
ant cells to anthracycline antibiotics [14,15]. A combined ap-
plication of anti-tumor drugs with pluronics resulted in the
accumulation of chemotherapeutics in tumor cells and de-
creased the side e¡ects of drugs on the immune system [16].
The reasons for these phenomena remain unclear.
The biological e¡ects of pluronics are possibly mediated by
their interaction with cell plasma membranes and the modu-
lation of their permeability. It is well known that polyethylene
oxide containing polymers can a¡ect biological membrane
structure. Pure polyethylene oxide (PEO) at 5% concentration
and more induces changes in the lipid bilayer hydration
sphere and causes membrane fusion [17]. Lower PEO concen-
trations (0.1^1%) induce changes in membrane £uidity [18].
PEO containing detergents such as Triton X-100 bind the
biological membranes so that their hydrophobic groups incor-
porate into the lipid bilayer, thus changing the membrane
structure and £uidity [19]. Ethylene oxide (EO) and propylene
oxide (PO) block copolymers can also interact with lipid bi-
layers, changing the thermodynamic properties of the latter
[20]. In the present work we have investigated the interaction
of two pluronic copolymers with membranes of di¡erent nor-
mal and malignant cells, and their in£uence on the membrane
£uidity.
2. Materials and methods
2.1. Cells
Mouse splenocytes were isolated from mouse spleen as described in
[21]. Brie£y, spleens of 6^8 months old BALB/c mice were washed
thoroughly in 5^10 ml of saline to remove contaminating blood and
carefully pounded in 2^3 ml DMEM medium. The powder was ¢l-
tered through gauze and centrifuged at 300^500Ug to gather spleno-
cytes. The cells were used immediately after isolation.
Erythrocytes were isolated from blood of BALB/c mice supple-
mented with EDTA. The cells were washed three times with
DMEM and used immediately. Mouse myeloma cells SP2/0 were cul-
tured in RPMI 1640 medium in the presence of 10% fetal calf serum,
0.075% sodium bicarbonate and 2 mM glutamine. The cells were
propagated as ascites tumors in BALB/c mice by intraperitoneal in-
jection of 5^8 million cells per mouse. Ascites £uids were collected 3^4
weeks after injection and the cells were gathered by centrifugation,
washed three times with saline and used immediately after isolation.
2.2. Tritium labelled pluronics
The radioactive label was introduced into the pluronic molecule
by treatment of a thin pluronic ¢lm with atomic tritium according
to [22]. Brie£y, 2 mg of pluronic L61 (EO)2(PO)30(EO)2 or P85
(EO)25(PO)40(EO)25 (Serva) dissolved in 2 ml of methanol was spread
over reaction bulb walls and the solvent was evaporated under re-
duced pressure. 0.01 Pa pressure has been achieved, tritium was in-
jected into the apparatus up to 0.5 Pa. The tritium-protium exchange
reaction was initiated by a short (10 s) heating impulse of a tungsten
helix at 2000‡C. After two 10 s heating impulses, the unincorporated
tritium was removed under vacuum and the procedure was repeated
with a new portion of tritium. Then the pluronic ¢lm was dissolved in
methanol and the solution was incubated for several days to remove
exchangeable tritium atoms. The solvent was evaporated under vac-
uum and the dissolution-evaporation procedure was repeated three
times. The residual material was dissolved in ethanol and puri¢ed
from products of the polymer decomposition by gel ¢ltration on a
Sephadex LH-20 column (1.1U25) using ethanol as an e¥uent. The
retention volume of the ¢rst peak containing most radioactive materi-
al corresponded to the molecular weight of intact pluronic. It was
collected and the solvent was evaporated under vacuo. Pluronic ¢nal
concentration was detected using the BaI2 assay [23]. The speci¢c
radioactivity of the labelled polymer depended on the ¢lm thickness
and labelling conditions and varied in most cases from 0.5^3 Ci/mmol.
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2.3. Binding of 3H-labelled pluronics with cells
30^60U106 cells were suspended in 1 ml of DMEM, containing 20
mM HEPES, kept 30 min at the appropriate temperature (4‡C or
37‡C) and incubated with 3H-pluronics for 120 min at the same tem-
perature. The ¢nal concentration of pluronic varied in 0.2^2 WM
intervals. This range of concentrations corresponds to the polymer
concentration in blood achieved during treatment with pluronic-based
formulas [16]. After incubation the cells were washed ¢ve times with
cold PBS by centrifugation at 500Ug and dissolved in 100 Wl of 1 M
NaOH. 25 Wl of the solubilized material were used for determination
of protein concentration according to Lowry [24] and 75 Wl were
neutralized with 225 Wl of 0.4 N HCl and mixed with 3 ml of Triton
X-100 containing toluene scintillation solution. Radioactivity was
then measured using a Delta-400 scintillation counter.
2.4. Cell membrane microviscosity
Cell membrane microviscosity was measured using £uorescence po-
larization of 1,6-diphenyl-1,3,5-hexatriene (DPH) (Reanal) according
to Shinitzky and Barneholtz [25] and Plasek and Jarolim [26]. Brie£y,
0.2 mM DPH in acetone was diluted 100-fold with Hanks’ solution
and the organic solvent was removed by the bubbling of the solution
with nitrogen for 90^120 min. The cell suspension in Hanks’ solution
(106 cells/ml) was mixed with an equal volume of the labelling solu-
tion and stirred for 60 min at room temperature. Incorporation of
DPH into the cell membrane results in a 10-fold increase of its £uo-
rescence [25,26]. The suspension of labelled cells was mixed with plur-
onic solutions and incubated at 37‡C for 1 h under gentle stirring.
Fluorescence anisotropy was then measured using a polarization spec-
tro£uorometer Hitachi F-4000, using an excitation wavelength 366 nm
and an emission wavelength 433 nm. Microviscosity of the membrane
hydrophobic area was calculated from the Perrin equation, ro being
0.368, d being 10 ns and C(r) being 8.6U105 poise s31 K31 respec-
tively as they were previously reported [25,27]
2.5. Isolation of mouse liver microsomes [28]
Liver (2 g) of an adult BALB/c mouse was homogenized in 6 ml 10
mM MOPS, pH 7.0 in a Polytron homogenizer (Kinematika, Sweden)
at power 4 (2 impulses each of 30 s) in an ice bath. The sample was
centrifuged at 600Ug in an Eppendorf centrifuge for 10 min. The
pellet, containing undisrupted cells and nuclei, was discarded and
supernatant was centrifuged at 46 000Ug using Beckman J2^21 cen-
trifuge with an 18.1 rotor. The pellet was resuspended in 6 ml of 10
mM MOPS bu¡er, pH 7.0 and centrifuged again at 46 000Ug for 60
min. Analysis of membrane marker enzymes showed that the micro-
somes preparation contained equal quantities of plasma membranes
and membranes of endoplasmic reticulum.
2.6. Small unilamellar liposomes labelled with DPH [29]
Small unilamellar liposomes were prepared from egg yolk phospha-
tidylcholine (Sigma) or the mixtures of phosphatidylcholine with cho-
lesterol or phosphatidylserine (Sigma). 10 mg of lipids in ethanol was
mixed with 10 nmol of DPH and dried under reduced pressure. The
material was suspended in 1 ml of PBS with vigorous shaking and
sonicated (frequency 22 kHz, 2U200 s) using an ultrasound generator
4710 (Cole-Palmer Instruments). The obtained suspension of vesicles
was centrifuged at 12 000 rpm on an Eppendorf centrifuge to remove
large particles. The mean hydrodynamic diameter of the liposomes
determined by quasi-elastic light scattering was proved to be 50^65
nm.
2.7. Determination of average cell size
The cells were placed in a hemocytometer and microphotographs at
phase contrast (1U400) were taken. Cell diameter was measured and
calculated in relation to the 50 Wm side of the small square in the
hemocytometer. The mean cell diameter was determined as an average
of at least 20 cells.
3. Results
The ability of pluronic copolymers to promote drug pene-
tration across biological barriers may result from their bind-
ing with cell membranes. To elucidate this point we investi-
gated the binding of two copolymers P85 and L61, di¡ering in
PPO/PEO ratio, with normal and tumor blood cells. Pluronic
concentration was varied in the 0.2^2 WM range, which cor-
responded to its concentration in the blood of animals treated
with pluronic-based formulas. In preliminary experiments we
showed that at 4‡C, when an active uptake of pluronic is
mainly inhibited [30], the binding reaction reached equilibrium
after a 2 h incubation. It turned out that the binding of both
pluronics with erythrocytes, splenocytes and myeloma cells
was described by nearly linear binding isotherms (Fig. 1)
which obviously indicates a non-speci¢c character of pluronic
binding with cells. This conclusion was con¢rmed by the fact
that bound 3H-labelled pluronic was not substituted by a 100-
fold excess of unlabelled copolymer.
The e⁄ciency of P85 and L61 pluronics binding with di¡er-
ent cells depended on the cell type, temperature and pluronic
hydrophobicity (Fig. 2). Binding data are presented on this
¢gure as a number of the copolymer molecules per 1 Wm2 of
cell surface. Comparison of binding e⁄ciency at 4‡C when
endocytosis should be inhibited gives information about the
in£uence of cell surface properties on the interaction with
pluronic. Obviously, erythrocytes are characterized with a
much lower binding e⁄ciency with both pluronics as com-
pared to lymphocytes and myeloma cells. Myeloma cells
bind pluronic somewhat less e¡ectively than splenocytes.
Binding e⁄ciency depends slightly upon pluronic hydro-
phobicity. The more hydrophobic L61 pluronic (HLB = 3)
bound to the cells 1.5^2.5 times more e¡ectively than the
water-soluble pluronic P85 (HLB = 16). These data are in a
good agreement with the previously published observation
that the therapeutic e¡ect of the hydrophobic PPO-rich L61
is higher than that of the more hydrophillic PEO-rich P85
pluronic [14^16].
The character of the copolymers binding with myeloma
cells and splenocytes was drastically changed at normal tem-
perature. At 37‡C a persistent accumulation of pluronic in the
cells occurred (data not shown), which was presumably due to
the £uid-phase endocytic uptake of the polymer adsorbed on
the cell surface. The amount of the copolymer accumulated in
cells can be estimated from the data of Fig. 2a,b as the di¡er-
ence between the amount of pluronic bound at 37‡C and 4‡C.
The results of such calculation are presented on Fig. 2c. Mye-
loma cells accumulated 3.5 times more copolymers as com-
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Fig. 1. Binding of 3H-labelled pluronics with lymphocytes (curves 1,
2), erythrocytes (curves 3, 4) and myeloma cells SP2/0 (curves 5, 6)
at 4‡C in DMEM medium. Curves 1, 3, 5 pluronic P85; curves 2,
4, 6 pluronic L61.
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pared to normal splenocytes. Erythrocytes did not accumulate
pluronics at all.
These results permit us to suggest that the physiological
e¡ects of pluronics in many cases can be mediated by their
adsorption on cell membranes. We applied the method of
£uorescence polarization to investigate changes in the bilayer
structure caused by pluronic binding. This method was pro-
posed more than 20 years ago and is based on the monitoring
of the £uorescence depolarization, which depends on the rate
of rotation of a £uorescent probe incorporated into the mem-
brane. In our work we used DPH which nowadays is the most
widely used probe for the measuring of membrane microvis-
cosity.
The Perrin equation gives a link between the polarization
anisotropy r and the viscosity of the probe microenvironment
in the bilayer (R) [25]:
ro
r
 1 CrT Wd
R
1
where ro is the £uorescence anisotropy of the probe at in¢n-
itely high viscosity (in polypropylene glycol solution at
370‡C), d is the excited state life-time, T the absolute temper-
ature, C(r) the structural parameter of the probe and R the
microviscosity, measured in poise.
Incorporation of DPH into the lipid bilayer resulted in a
drastic increase of the £uorescence intensity due to changes of
DPH microenvironment polarity. The probe has been previ-
ously reported to localize in the hydrophobic region of the
biological membrane [25]. Thus, changes in £uorescence ani-
sotropy of DPH give information about structural alterations
in the hydrophobic region of the bilayer. Incubation of DPH-
labelled mouse liver microsomes with pluronics (Fig. 3a)
showed that both P85 and L61 copolymers decreased the
membrane microviscosity in a threshold manner. The critical
pluronic concentration, which caused an abrupt decrease of
microviscosity (3 WM for P85 and 1 WM for L61) corresponds
approximately to the critical micellization concentration
(CMC) of the pluronic. So it may be supposed that pluronic
micelles can extract the probe from the membrane, and there-
fore, the microviscosity observed at high pluronic concentra-
tions is a characteristic of micelles, not a bilayer. To verify
this hypothesis we incubated DPH-labelled microsomes with
pluronics, sedimented the microsomes at 46 000Ug (1 h), re-
suspended the pellet in the initial volume of bu¡er and meas-
ured the £uorescence intensity of the supernatant and the
pellet. From these data, the portion of the membrane-bound
probe was calculated and presented in Fig. 3b as a function of
the pluronic concentration. It could be seen that pluronic P85
extracted the probe from the microsomes, in contrast to plur-
onic L61 that did not extract DPH. These results indicated
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Fig. 3. In£uence of L61 (curve 1) and P85 (curve 2) copolymers on
the microviscosity of mouse liver microsomes at 37‡C (a) and on
the portion of DPH associated with membranes (b).
Fig. 2. Number of bound P85 and L61 copolymers chains per 1 Wm2
of cell surface after incubation with 1 WM copolymer solution for
2 h at 4‡C (a) and at 37‡C (b). c shows the amount of P85 and
L61 copolymers accumulated in 106 di¡erent cells calculated as a
di¡erence between amount of the copolymer bound at 37‡C and at
4‡C.
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that the increase of pluronic L61 concentration up to 10 WM
did not in£uence DPH localization in the membrane but in-
duced changes in the £uorescence anisotropy of the probe.
Therefore, these changes can be attributed to the alteration
of the bilayer structure caused by the pluronic incorporation
into the membrane. On the other hand, we implied that plur-
onic P85 concentration should not exceed 2 WM to avoid
DPH redistribution between the membrane and pluronic mi-
celles.
Interaction of both pluronic copolymers with small mono-
lamellar lipid vesicles combined from pure egg yolk phospha-
tidylcholine and its mixture with cholesterol and phosphati-
dylserine resulted in small if any changes in membranes
microviscosity (results are not shown). So, the membranes
built from pure lipids are characterized by low sensitivity to
the £uidising e¡ect of pluronic copolymers.
The results given in this paper show that pluronics can bind
to cell membranes and induce changes in the packing of mem-
brane lipids. Comparisons of the in£uence of pluronics on
liver microsomes and lipid vesicles show that the e¡ect de-
pends on membrane composition. Therefore, we investigated
the pluronic in£uence on microviscosity of membranes of dif-
ferent blood cells. Fig. 4 shows the pluronics e¡ect on mem-
brane microviscosity of mouse erythrocytes, splenocytes and
myeloma SP2/0 cells. Myeloma cell membranes in the absence
of pluronics have very low microviscosity that is in good
agreement with the previously reported data concerning mem-
brane £uidity of tumor cells [31^33]. The microviscosity of
splenocyte and erythrocyte membranes increased in the pres-
ence of rather low pluronic concentration (approximately 0.1
WM) and decreased as its concentration reached 1 WM. While
the microviscosity of mouse myeloma cells membranes under-
went a constant decrease in the 0.1^1 WM pluronic concen-
tration range. No redistribution of DPH between cells and
pluronic solution was detected in the studied concentration
range. This fact allows us to conclude that pluronic binding
to tumor cells membranes resulted in the £uidizing of the
bilayer, whereas normal cells microviscosity increases at a
therapeutically active pluronic concentration (0.4^1 WM).
4. Discussion
The ability of pluronic copolymers to a¡ect the permeabil-
ity of biological barriers has been widely discussed in litera-
ture [1,2,9^11]. It has been reported that pluronics can in£u-
ence the biodistribution of anti-tumor drugs enhancing the
speci¢city of their action [16]. In the present work, we eval-
uated the binding of two pluronic copolymers with normal
and tumor blood cells. Binding of both copolymers with all
investigated cell types is non-speci¢c and its absolute value is
rather low. Only 0.01^0.05% of the added copolymer absorbs
on cells in all cases. Bound pluronic molecules occupy no
more than 1^3% of cell surface. The binding e⁄ciency de-
pends upon copolymer HLB: binding of the hydrophobic
L61 copolymer is 1.5^3 times higher than that of less hydro-
phobic P85 pluronic. Binding e⁄ciency depends strongly on
the nature of cells, pluronics binding with erythrocytes being
nearly 10-fold less than with lymphoid cells. It is reasonable to
suppose that this e¡ect is mainly due to the di¡erence in the
plasma membrane composition of the investigated cells. Er-
ythrocyte plasma membranes are known to contain more cho-
lesterol than the membranes of lymphocytes and tumor cells
[34], so it is reasonable to suggest that the £uidity of the
membrane determines to some extent its ability to bind plur-
onic copolymers.
Assuming that binding at 4‡C is chie£y caused by adsorp-
tion of the polymer on the cell surface, the ability of cells to
accumulate pluronic by endocytic uptake at the physiological
temperature can be estimated as a di¡erence between the co-
polymers binding at 37‡C and 4‡C (Fig. 2c). Investigation of
the temperature dependence of the copolymer uptake by dif-
ferent cells revealed peculiarities of the tumor cells. Temper-
ature-dependent uptake of L61 copolymer by SP2/0 myeloma
cells at 37‡C was twice more e¡ective than at 4‡C. It can be
supposed that this uptake is due to £uid-phase endocytosis or
copolymer di¡usion across the membrane. In contrast, normal
splenocytes absorb only 20^30% more pluronics at 37‡C than
at 4‡C, indicating that tumor cells can accumulate three times
more of the copolymer than normal cells : so binding e⁄ciency
of pluronic copolymers with tumor and normal cells is similar,
however the character of their association is quite di¡erent.
Normal cells adsorb most polymers on their surface, whereas
tumor cells accumulate them inside.
The observed peculiarities of the copolymers binding with
myeloma cells can be mainly determined by the composition
and physical properties of the plasma membrane. Therefore,
we investigated the in£uence of the copolymers on plasma
membrane microviscosity in di¡erent cells. The e¡ect of plur-
onic copolymers on normal and tumor cell membranes was
proved to be quite di¡erent. Microviscosity of tumor cells
membranes decreased, whereas that of normal cells increased
after incubation with rather low (4U1037^1036 M) pluronic
L61 concentrations. P85 copolymer induced similar changes in
the membrane microviscosity though less pronounced.
The physico-chemical mechanisms of cell sensitivity to the
disturbing action of the macromolecular £uidizer is the sub-
ject of further investigations. The preferred £uidizing of tumor
cell plasma membranes can be a general basis of selective
delivery of drugs in tumor cells.
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Fig. 4. In£uence of pluronics P85 (curves 1, 3, 5) and L61 (curves
2, 4, 6) on the microviscosity of membranes of (a) mouse erythro-
cytes, (b) splenocytes, (c) myeloma SP2/0 cells. All experiments were
performed at 37‡C in Hanks’ solution.
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